J.P. Morgan Notebook: Tuesday January 14

Welcome to “The Pink Sheet” DAILY’s round-up of news and notes from the second day of the 2014 J.P. Morgan health care conference, including news from ZS Pharma, Aisling Capital, Astellas, and Moderna.

After a rocky IPO start, Relypsa Inc. shares climbed to hit almost $30 on Jan. 14, close to a 52-week high and up steeply from the $11 IPO price in November 2013. A one-day stock climb of 9% followed a data update from the company at J.P. Morgan. It now has a market cap of almost $860 million.

At the conference, the company updated Phase III data for its patiromer to treat hyperkalemia. In the maintenance portion of...

More from United States

More from North America